603669 靈康藥業
按盤價 
5.580 -0.190 (-3.293%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.347 | -27.803 | -15.377 | -14.668 | -15.104 |
| 總資產報酬率 ROA (%) | 1.893 | -16.362 | -9.081 | -8.707 | -8.964 |
| 投入資產回報率 ROIC (%) | 2.190 | -19.197 | -10.029 | -9.094 | -9.260 | 邊際利潤分析 |
| 銷售毛利率 (%) | 41.313 | 43.713 | 46.881 | 46.672 | 67.809 |
| 營業利潤率 (%) | 8.486 | -60.770 | -33.906 | -75.690 | -65.226 |
| 息稅前利潤/營業總收入 (%) | 12.574 | -40.554 | -33.207 | -76.447 | -65.670 |
| 淨利潤/營業總收入 (%) | 8.200 | -59.922 | -34.431 | -76.967 | -67.711 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 121.240 | 86.856 | 67.780 | 103.963 | 89.066 |
| 價值變動淨收益/利潤總額(%) | -21.064 | 1.539 | 5.339 | 9.628 | 4.300 |
| 營業外收支淨額/利潤總額(%) | -1.855 | -1.271 | -0.814 | 1.308 | 0.069 | 償債能力分析 |
| 流動比率 (X) | 1.216 | 1.098 | 2.675 | 3.626 | 3.743 |
| 速動比率 (X) | 1.051 | 0.922 | 2.548 | 3.393 | 3.581 |
| 資產負債率 (%) | 42.938 | 43.956 | 38.681 | 42.690 | 38.849 |
| 帶息債務/全部投入資本 (%) | 33.310 | 34.200 | 26.498 | 39.190 | 36.010 |
| 股東權益/帶息債務 (%) | 197.877 | 189.971 | 274.441 | 153.346 | 176.783 |
| 股東權益/負債合計 (%) | 132.896 | 127.500 | 158.526 | 134.249 | 157.405 |
| 利息保障倍數 (X) | 2.963 | -2.085 | -78.049 | -310.910 | 164.745 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 191.645 | 278.698 | 145.938 | 143.506 | 134.245 |
| 存貨周轉天數 (天) | 95.213 | 110.976 | 75.527 | 181.612 | 194.865 |
| 備註： | 即時報價更新時間為 18/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
